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Abstract
Clinical endometritis (CE) is a serious 
disease leading to poor reproductive 
performances in lactating dairy cows, thus 
diminishing farm profitability. To preserve 
optimum reproductive efficiency, various 
strategies and therapeutic approaches have 
been proposed to manage cows with CE, often 
with contradictory results. Thus, investigating 
new paths to CE treatment is economically 
important. The aim of the present study 
was to test the efficacy of three therapeutic 
protocols on the clinical cure rate of CE, and 
improvement of reproductive performance. 
Cows with CE (n=42), 21–38 days in milk 
(DIM), were assigned to three treatment 
groups: PGF: cows (n=19) were treated 
systemically with two doses of d-cloprostenol, 
a PGF2α analogue, at 14-days intervals; CEFAX: 
cows (n=10) received an intrauterine infusion 
of the combined antibiotics Cefacetrile and 
Rifaximin; and NAX: cows (n=13) received 
systemic treatment with Ceftiofur crystalline 
free acid (CCFA). A control group included 
cows (n=36) free from CE (healthy group: HE). 
All cows were clinically re-examined after the 
end of the treatment protocol. The clinical cure 
rate was 73.7%, 80% and 69.2% in PGF, CEFAX, 
and NAX groups, respectively (P>0.05). 
The HE group had a significantly shorter 
calving to first service interval compared to 
CEFAX and PGF groups (P<0.05), however 
the difference was not significant with NAX 
group. The mean calving to fertilizing service 
interval (CFI) was slightly higher in all three 
treatment groups compared to the HE group, 
however the difference was not significant 
(P>0.05). CEFAX protocol resulted in shorter 
but not statistically significant CFI, compared 
to the PGF and NAX protocols. Services per 
conception rate were slightly lower (1.7) in the 
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CEFAX group compared to HE (1.75), PGF 
(1.84) and NAX (2.23) groups, however these 
differences were not significant. First service 
conception rate and conception rate at 105 
DIM did not differ statistically between the 
treatment groups. While the difference was 
not significant, CEFAX protocol had slightly 
better cure rate for CE, reducing the number 
of services per conception and boosting the 
resumption of ovarian activity after calving. 
Validating these finding on a larger herd size 
will improve the accuracy of these findings.
Key words: clinical endometritis; treatment; 
cure rate; reproductive performance
Introduction
During parturition and soon after 
calving, in most cows, the uterus is 
invaded mainly by commensal and 
opportunistic bacteria (i.e. Escherichia coli, 
Trueperella pyogenes, and Fusobacterium 
necrophorum) (Williams et al., 2005; 
Malinowski et al., 2011; Brick et al., 2012; 
Szenci et al., 2018). Uterine involution 
is the physiological process leading to 
epithelium regeneration, endometrial 
repair, microbial clearance of the uterine 
lumen and resumption of ovarian activity 
(Sheldon, 2004; Kočila et al., 2013; Sheldon 
and Owens, 2017).
Several clinical trials have shown 
that clinical endometritis (CE) declines 
reproductive efficiency in dairy cows, 
indirectly lowering farm profitability 
(Kim and Kang, 2003; Brick et al., 2012; 
Giuliodori et al., 2013; Đuričić et al., 
2014). CE is an afebrile inflammation 
of the endometrium, diagnosed by the 
detection of abnormal uterine discharges 
in the vagina beyond 21 days in milk 
(DIM) (Sheldon et al., 2006). The disease 
is highly prevalent, affecting about 40% 
of lactating dairy cows (Kaufmann et al., 
2010; Ahmadi et al., 2019).
The diagnosis of CE can be conducted 
by rectal palpation searching for uterine 
fluctuation or by vaginal examination 
(e.g. vaginoscopy or Metricheck®) based 
on clinical symptoms, mainly pus and a 
fetid odour of vaginal discharges (VDs) 
(Runciman et al., 2009). Furthermore, CE 
can be diagnosed subclinically by uterine 
biopsy or cytology to detect uterine 
inflammation (Földi et al., 2006). Once CE 
is diagnosed, a good treatment protocol 
should be applied. However, CE therapy 
is greatly debated in the context of its 
effect on reproductive performances of 
dairy cows (i.e., first service conception 
rate (FSCR), calving to first service interval 
(CFSI), calving to fertilizing service 
interval (CFI), and number of services 
per conception (NSPC)). Treatment 
effectiveness depends on the medicines 
administered, postpartum period of 
treatment, stage of uterine involution, 
and ovarian activity (Lefebvre and 
Stock, 2012). Various remedies have been 
proposed, including uterine antibiotics 
(Mari et al., 2012; Tison et al., 2017), 
systemic antibiotics (Kaufmann et al., 
2010; Brick et al., 2012), antiseptics (Mido 
et al., 2016), enzymes (Drillich et al., 
2005), dextrose (Brick et al., 2012; Ahmadi 
et al., 2019), liquid paraffin (Makki et al., 
2017), nonsteroidal anti-inflammatory 
drugs (NSAIDs) (Königsson et al., 2001), 
hormones (e.g. PGF2α) (Kasimanickam 
et al., 2005) and homeopathic remedies 
(Arlt et al., 2009), all of which have been 
widely tested.
The aim of the present study was 
to compare the clinical cure rate of 
three therapeutic protocols using 
systemic prostaglandin (PGF2α) 
analogues (d-cloprostenol), intrauterine 
application of intramammary applicators 
composed of an antibiotic association 
(Cefacetrile+Rifaximin), and a systemic 
antibiotic (Ceftiofur crystalline free acid: 
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CCFA) in cows suffering from CE, and 
to assess the effects of these protocols on 
reproductive performance in comparison 
with healthy cows. 
Materials and methods
Animals
The study was conducted between 
April 2018 and December 2019 on six 
dairy farms in Sougueur, in central-
west Algeria. All farms had an annual 
breeding system, and no synchronization 
programmes for oestrus or ovulation 
were used. Cows were housed in loose 
housing system with a similar feeding 
system (the ration consisted of meadow 
fodder or corn silage with vetch oats 
hay, and commercial concentrates were 
added according to milk yield). Water 
was given ad libitum. Animals were 
milked twice a day and the average daily 
milk production was 13.7 ± 0.6 kg/cow. 
The body condition score (BCS) of the 
selected animals ranged between 2.75 
and 3.25 according to criteria proposed 
by Ferguson et al. (1994).
Gynaecological examination and 
enrolment criteria 
Only cows between 21 and 38 DIM 
(Exam 1) were included in the study. The 
perineal region was clinically inspected 
to detect abnormal VDs, while rectal 
palpation and vaginoscopy were used 
to determine the origin of VDs (Plöntzke 
et al., 2011). Transrectal ultrasound 
examinations (Dramanski I-Scan, 
Dramanski® animal profi, Poland) were 
performed to monitor uterine liquid 
accumulation, wall thickness, uterine 
lumen diameter and ovarian structures. 
VDs were scored according to Williams 
et al. (2005). Cows with VDs ≥ 1 were 
considered as having CE (Madoz et al., 
2017; Tison et al., 2017). Cows having 
vaginal laceration at calving or were 
subject to caesarean section and/or 
received any intrauterine or systemic 
antibiotic or hormonal treatment during 
the last 15 days before the start of the 
study were excluded. After the onset 
of the experimental study, any cow 
receiving a treatment for other diseases 
than CE was excluded. Cows that were 
culled or sold before the pregnancy 
diagnosis were excluded from the 
analysis. 
Treatment protocols
Cows were randomly allocated to 
four experimental groups, as follows. 
The PGF protocol included 19 cows that 
received two intramuscular injection of 
150 µg d-cloprostenol a PGF2α analogue 
(Dalmazin®, FATRO S.p.A. Veterinary 
Pharmaceutical Industry, Via Emilia, 
285, 40064 Ozzanodell’Emilia (Bologna), 
Italy) at 14-day intervals. The CEFAX 
protocol included 10 cows that received 
simultaneous intrauterine infusion 
of two intramammary applicators 
(Cefaximin-L spray®, FATRO S.p.A., 
Italy). Each 15 g applicator contains 
the antibiotic association of Cefacetrile 
(200 mg) and Rifaximin (100 mg), the 
mixture was infused in the uterus using 
a solid stainless-steel rod of 50 cm in 
length. The NAX protocol included 13 
cows that received a single dose of 6.6 
mg/kg of bodyweight (BW) of CCFA 
subcutaneously behind the ear (Naxcel®, 
Zoetis, USA). The HE group included 36 
healthy cows without clinical symptoms 
of CE. To determine the cure rate of 
protocols, all treated cows were re-
examined two weeks after the end of the 
treatment (Exam 2) (35–53 DIM). The 
clinical cure was defined as a cow with 
CE at Exam 1 that was subsequently 
described as clinically healthy (VDs=0) 
at Exam 2. Reproductive parameters 
were defined and are summarized in 
Table 1. The voluntary waiting period 
was set at 50 days postpartum, and 
pregnancy controls were performed 
by transrectal ultrasonography at 35±4 
days post mating. The study was carried 
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out according to the guidelines of the 
Institutional Animal Care Committee 
of the Algerian Higher Education and 
Scientific Research.
Statistical analysis
Data were analysed using IBM SPSS 
version 24.0. (IBM SPSS Statistics for 
Windows, Version 24, USA). Cure rate, 
first service conception rate (FSCR), and 
conception rate until 105 DIM (CR105) 
were compared among the experimental 
groups using the Chi-square test 
or Fisher’s exact test. Reproductive 
parameter data (calving to first service 
interval (CFSI), calving to fertilizing 
service interval (CFI), and number 
of services per conception (NSPC)) 
were presented as means ± standard 
deviation (SD), and the Mann-Whitney 
nonparametric U-test was used for 
statistical comparison between groups. 
Statistical significance was set at P<0.05.
Results
The clinical cure rate of CE cows was 
73.7%, 80% and 69.2% for PGF, CEFAX, 
and NAX protocols, respectively (P>0.05). 
FSCR did not differ significant between 
Table 1. Definitions of reproductive parameters for evaluating the effect of the treatment protocol in 
dairy cows 
Parameters Definition
Cure rate (%) The number of cured cows on day 14 divided by the number of treated cows in each group*100
Calving to first service interval 
(CFSI) (days) The number of days from calving to first service
Calving to fertilizing service 
interval (CFI) (days) The number of days from calving to successful service
Number of services per 
conception (NSPC) The number of services required to get a cow pregnant
First service conception rate 
(FSCR) (%)
The number of cows get pregnant at first service divided 
by the total number of serviced cows*100
Conception rate at 105 DIM 
(CR105) (%)
The number of pregnant cows until 105 days divided by 
the total number of mated cows *100
Table 2. Cure rate and reproductive performances indices in the control and treatment protocols. 
Parameters Healthy PGF CEFAX NAX
Cure rate % (n) - 73.7 (14/19) 80 (8/10) 69.2 (9/13)
FSCR% (n) 36.1 (13/36) 36.8 (7/19) 40 (4/10) 23.1 (3/13)
CR105 (n) 86.1 (31/36) 73.7 (14/19) 70 (7/10) 69.2 (9/13)
CFSI (mean±SD) days 59.94±11.64a 75.21±27.08b 69.90±8.42b 67.69±13.2
CFI (mean±SD) days 76.50±17.74 93.32±35.43 85.70±21.25 94.0±30.92
NSP (mean±SD) days 1.75±0.69 1.84±0.83 1.70±0.67 2.23±1.01
Values in lines with different letters (a,b) are significantly different (P<0.05). FSCR = First service conception rate; 
CR105= Conception rate at 105 DIM; CFSI = calving to first service interval; CFI= calving to fertilizing service interval; 
NSPC= number of services per conception
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any treatment protocol and the control 
group (P>0.05). The lowest FSCR was 
found in the NAX group (23.1%). The 
highest CR105 was found in the HE group 
(86.1%), however the difference was 
not significant between any treatment 
protocols and the control group (P>0.05). 
CFSI was significantly higher in both the 
PGF (75.21±27.08) and CEFAX groups 
(69.90±8.42) compared to HE group (59.94 
±11.64) (P<0.05). Compared to the HE 
group, CFI was about 17 days (d), 9d, and 
18d longer in the PGF, CEFAX and NAX 
groups, respectively, though differences 
were not significant (P>0.05). NSPC was 
slightly lower (1.7) in the CEFAX group 
compared to the HE (1.75), PGF (1.84) and 
NAX (2.23) groups, though differences 
were not significant (P>0.05) (Table 2).
Discussion
Clinical endometritis is an important 
postpartum uterine disease that alters 
normal reproductive performance, 
reducing subsequent fertility and thus 
has a negative impact on the farm 
profitability. The aim of this study was to 
evaluate the effect of different treatment 
protocols in cows with CE on the clinical 
cure rate and reproductive performance.
The selected protocols were based on 
in vitro findings where Ceftiofur, a third 
generation cephalosporin, Cephapirin, 
a first generation cephalosporin, and 
Rifaximin, a semi- synthetic antibiotic, 
were concluded to be effective in the 
treatment of uterine infection (Malinowski 
et al., 2011). The three molecules are broad 
spectrum antibiotics and active against 
gram-positive and gram-negative bacteria, 
even in an anaerobic environment. 
Furthermore, Galvão et al. (2009), reported 
that using intramammary applicators of 
Ceftiofur (125 mg) by intrauterine route 
resulted in concentrations of Ceftiofur 
in uterine fluids (>0.50 µg/mL) sufficient 
to inhibit growth of relevant pathogens 
involved in uterine infections during 
the first two months of calving (Witte 
et al., 2011). Since CE is a pathological 
inflammation of the endometrium, 
Flammini et al. (2018) revealed surprising 
anti-inflammatory properties of Rifaximin 
on the bovine endometrial cell challenged 
with Lipopolysaccharide (LPS) of 
Escherichia coli. 
The prostaglandin F2α has been com-
monly used as remedy for postpartum 
diseases. Several studies have revealed 
that PGF2α and its analogues effectively 
improve reproductive performance and 
increase the cure rate of uterine diseas-
es (Ahmadi et al., 2018), especially those 
associated with the presence of corpus lu-
teum (CL). In the literature, it seems that 
using two injections of PGF2α at a 14-day 
interval is the most common and effec-
tive therapeutic protocol for CE (Lefebre 
and Stock, 2012). The use of PGF2α in CE 
therapy is intended to induce luteoly-
sis of CL, boost uterine contraction and 
thus accelerate the uterine involution 
and the resumption of ovarian activity, 
which will reduce the occurrence of CE 
(Hoedemaker, 1998; Kasimanickam et al., 
2005). Furthermore, PGF2α has immuno-
logical properties, as it increases uterine 
leukotriene B4 secretions that supports 
chemotaxis, cell-mediated cytotoxicity, 
phagocytosis, and lymphocyte function, 
all of which will control and modulate 
uterine inflammation (Slama et al., 1993; 
Lefebvre and Stock, 2012). Although, it 
has been demonstrated that a systemic 
antimicrobial treatment of CE is not jus-
tified since the possible infection in the 
case of CE is limited to the superficial lay-
er of the endometrium (Földi et al., 2006), 
Kaufmann et al. (2010) reported that sys-
temic treatment with 1.0 mg/kg BW of 
Ceftiofur over three consecutive days in 
cows with signs of clinical endometritis 
21–27 DIM had the same effect as treat-
ment with two doses of PGF2α at a 14-day 
interval. Also, systemic antibiotic admin-
istration may provide equal distribution 
of a therapeutic concentration to different 
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organs, preventing possible passage of 
bacteria to the uterus. Witte et al. (2011) 
reported that subcutaneous administra-
tion of CCFA (6.6 mg/kg BW) after par-
turition for healthy puerperal dairy cows 
with normal parturition resulted in effec-
tive and durable concentrations of Ceft-
iofur derivatives in endometrial tissues 
and lochia that exceed the recommend-
ed minimal inhibitory concentrations 
for many pathogens detected in genital 
tract pathologies, mainly Escherichia coli, 
Trueperella pyogenes, Fusobacterium necro-
phorum and Prevotella melaninogenica. In 
their study, the mean concentration of 
desfuroylceftiofur acetamide, the active 
metabolite of Ceftiofur reached its high-
est level in the endometrial tissue 24 h af-
ter systemic administration of CCFA, and 
remained high until day 7, after which it 
started to decline.
In the current study, the clinical cure 
rate in the three treatment groups was 
around 70%. These results indicated that 
the three treatments helped to clinically 
resolve CE. In a previous study, the 
clinical cure rate of systemic Ceftiofur or 
two doses of PGF2α was 74.2% and 80.2%, 
respectively (Kaufmann et al., 2010), 
which is similar to our findings. Also, 
Mari et al. (2012) established a scoring 
system for evaluating CE severity where a 
higher score indicates a more severe case 
of CE. The authors found that intrauterine 
infusion of 500 mg Cephapirin, a first 
generation cephalosporin having similar 
activity to Cefacetrile, decreased the 
score value from 5.91 to 1.0 three weeks 
after treatment. The likelihood for clinical 
cure decreased with VD score (Eslami et 
al., 2015) and the severity of endometrial 
lesions and the detection of Trueperella 
pyogenes (Madoz et al., 2017).
The conception rate of the HE 
group and treated cows did not differ 
significantly among groups at 105 DIM 
(71.4% in average for treated groups 
vs 86.1% in HE group) (P>0.05). This 
result is consistent with Ahmadi et al. 
(2018), who found that the percentage of 
pregnant cows at 100 and 200 DIM was 
similar among groups (46% in average at 
100 DIM and 82% at 200 DIM). Soon after 
calving, cows are inevitably exposed to a 
negative energy balance that affects the 
effectiveness of immune function and 
metabolism, resulting in several diseases 
(Giuliodori et al., 2013). However, 
adjusting animal feeding is effective in 
reducing the effects of negative energy 
balance and preventing BCS loss (Galvão, 
2013). 
To be highly effective, CE treatment 
should not only increase the cure rate 
but also improve the reproductive 
performance of the female. Cows in the 
HE group had a significantly shorter 
CFSI compared to the three treatment 
groups. The median time to first service 
was about 15d, 10d, and 8d higher in 
the PGF, CEFAX and NAX groups, 
respectively. CE is an inflammation of the 
endometrium and often associated with 
disruption of the endometrial epithelium 
and reduction and dysfunction of 
endometrial glands (Sheldon et al., 2009b; 
Adnane et al., 2018), extending uterine 
involution and delays the resumption of 
normal ovarian activity and pregnancy 
(Tison et al., 2017).
While the difference was not 
significant, the highest number of 
services per conception was shown in 
NAX groups compared to the other 
groups. This could be explained by the 
fact that the effective concentration of the 
antibiotic did not reach the endometrium 
in the appropriate time and for the 
required duration, or the endometrium 
was affected by pathogens resistant 
to Ceftiofur (Malinowski et al., 2011). 
Santos et al. (2010) reported that 38.9% of 
Trueperella pyogenes isolates were resistant 
to Ceftiofur. Likewise, intrauterine 
infusion of Ceftiofur reduced bacterial 
contamination of the uterus, decreased 
the prevalence of CE but failed to reduce 
the prevalence of subclinical endometritis 
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(Galvão et al., 2009). Since endometritis 
is a pathological inflammation and the 
causative relation with bacteria is highly 
debated, many researchers assumed 
that even after the resolution of clinical 
symptoms of the disease, subfertility 
associated with endometritis persists 
(Eslami et al., 2015), and subclinical 
endometritis may develop (Sheldon et 
al., 2009a). Unfortunately, we did not 
diagnose subclinical endometritis as 
it was beyond the scope of this study. 
The cytological cure rate based on the 
neutrophil level in the endometrium was 
higher in cows with CE that received 
intrauterine Cephapirin or systemic PGF2α 
at 28–35 DIM compared to untreated 
cows (Makki et al., 2017). Therefore, 
associating the cytological cure rate with 
the clinical diagnosis would assist in 
determining which treatment protocol is 
more effective for CE treatment.
Conclusion
According to its effect on cure rate and 
reproductive performances, treatment 
with Cefaximin-L spray® intramammary 
applicators helped to resolve CE in 
dairy cows and to slightly improve the 
reproductive performances. We could 
not investigate the cytological cure rate 
as subclinical endometritis was not 
diagnosed. Further research on a larger 
sample size is planned to overcome this 
limit, as we believe that the reproductive 
parameters remained lower than normal 
due to the presence of subclinical 
inflammation in those animals, which 
required treatment other than antibiotics. 
Modulating uterine inflammation would 
be the next step toward endometritis 
management. 
Acknowledgements
The authors thank participating farms and their 
staff for their cooperation and amiable hospitality.
References
1. ADNANE, M., K. G. MEADE and C. O’FARRELLY 
(2018): Cervico-vaginal mucus (CVM) – an 
accessible source of immunologically informative 
biomolecules. Vet. Res. Commun. 42, 255-263. 
2. AHMADI, M. R., M. MAKKI, A. MIRZAEI and H. 
R. GHEISARI (2019): Effects of hypertonic dextrose 
and paraffin solution as non-antibiotic treatments of 
clinical endometritis on reproductive performance 
of high producing dairy cows. Reprod. Domest. 
Anim. 54, 762-771. 
3. AHMADI, M. A., S. MOGHEISEH, A. MIRZAEI, 
S. NAZIFI and E. EISAFALLAH (2018): Treatment 
of cows with clinical endometritis III as cows 
affected by pyomètre–Non antibiotic treatment of 
severe clinical endometritis. Asian. Pac. J. Reprod. 
7, 185-190.
4. ARLT, S., W. PADBERG, M. DRILLICH and W. 
HEUWIESER (2009): Efficacy of homeopathic 
remedies as prophylaxis of bovine endometritis. J. 
Dairy Sci. 92, 4945- 4953. 
5. BRICK, T. A., G. M. SCHUENEMANN, S. BAS, J. 
B. DANIELS, C. R. PINTO, D. M. RINGS and P. J. 
RAJALA-SCHULTZ (2012): Effect of intrauterine 
dextrose or antibiotic therapy on reproductive 
performance of lactating dairy cows diagnosed 
with clinical endometritis. J. Dairy Sci. 95, 1894-
1905. 
6. DRILLICH, M., D. RAAB, M. WITTKE and 
W. HEUWIESER (2005): Treatment of chronic 
endometritis in dairy cows with an intrauterine 
application of enzymes. Theriogenology 6, 
1811-1823.
7. ĐURIČIĆ, D., M. LIPAR and M. SAMARDŽIJA 
(2014): Ozone treatment of metritis and endometritis 
in Holstein cows. Vet. arhiv 84 103-110.
8. ESLAMI, M., M. BOLOURCHI, H. A. SEIFI, F. 
ASADI and R. AKBARI (2015): Treatment of 
clinical endometritis in dairy cows by previously 
used controlled internal drug release devices. 
Theriogenology 84, 437-445. 
9. FERGUSON, J. D., D. T. GALLIGAN and N. 
THOMSEN (1994): Principal Descriptors of Body 
Condition Score in Holstein Cows. J. Dairy Sci. 77, 
2695-2703. 
10. FLAMMINI, L., L. MANTELLI, A. VOLPE, G. 
DOMENICHINI, R. DI LECCE, M. DONDI, A. M. 
CANTONI, E. BAROCELLI and F. QUINTAVALLA 
(2018): Rifaximin anti-inflammatory activity on 
bovine endometrium primary cell cultures: a 
preliminary study. Vet. Med. Sci. 4, 326-332. 
11. FÖLDI, J., M. KULCSÁR, A. PÉCSI, B. HUYGHE, C. 
DE SA, J. A. C. M. LOHUIS and G. HUSZENICZA 
(2006): Bacterial complications of postpartum 
uterine involution in cattle. Anim. Reprod. Sci. 96, 
265-281. 
12. GALVÃO, K. N., L. F. GRECO, J. M. VILELA, M. 
F. SÁ FILHO and J. E. P. SANTOS (2009): Effect 
of intrauterine infusion of ceftiofur on uterine 
health and fertility in dairy cows. J. Dairy Sci. 92, 
1532-1542. 
SALEH BOUDELAL, MOUNIR ADNANE and ABDELATIF NIAR
VETERINARSKA STANICA 53 (3), 273-281, 2022.280
13. GALVÃO, K. N. (2013): Uterine diseases in dairy 
cows: understanding the causes and seeking 
solutions. Anim. Reprod. 10, 228-238
14. GIULIODORI, M. J., R. P. MAGNASCO, D. BECU-
VILLALOBOS, I. M. LACAU-MENGIDO, C. A. 
RISCO and R. L. DE LA SOTA (2013): Clinical 
endometritis in an Argentinean herd of dairy cows: 
Risk factos and reproductive efficiency. J. Dairy Sci. 
96, 210-218. 
15. HOEDEMAKER, M. (1998): Postpartum 
pathological vaginal discharge: to treat or not to 
treat. Reprod. Domest. Anim. 33, 141-146.
16. KASIMANICKAM, R., T. F. DUFFIELD, R. A. 
FOSTER, C. J. GARTLEY, K. E. LESLIE, J. S. 
WALTSON and W. H. JOHNSON (2005): The 
effect of a single administration of cephapirin or 
cloprostenol on the reproductive performance 
of dairy cows with subclinical endometritis. 
Theriogenology 63, 818-830. 
17. KAUFMANN, T. B., S. WESTERMANN, M. 
DRILLICH, J. PLÖNTZKE and W. HEUWIESER 
(2010): Systemic antibiotic treatment of clinical 
endometritis in dairy cows with ceftiofur or two 
doses of cloprostenol in a 14-d interval. Anim. 
Reprod. Sci. 121, 55-62. 
18. KIM, I. H and H. G. KANG (2003): Risk Factors 
for Postpartum Endometritis and the Effect of 
Endometritis on Reproductive Performance in 
Dairy Cows in Korea. J. Reprod. Develop. 49, 
485-491. 
19. KOČILA, A. JANŽEK, D. GRAČNER, 
T. DOBRANIĆ, D. ĐURIČIĆ, N. 
PRVANOVIĆ, N. FILIPOVIĆ, G. 
GREGURIĆ GRAČNER, LJ. BEDRICA, F. 
MARKOVIĆ and M. SAMARDŽIJA  (2013): 
Vergleich von Progesteronkonzentrationen, 
Energiebilanzkennwerten und körperlicher 
Verfassung bei Milchkühen mit verschiedener 
Milchleistung im Puerperium. Tierärztl. Umsch. 68, 
266-274.
20. LEFEBVRE, R. C and A. E. STOCK (2012): 
Therapeutic efficiency of antibiotics and 
prostaglandin F2α in postpartum dairy cows with 
clinical endometritis: an evidence-based evaluation. 
Vet. Clin. Food. Anim. 28, 79-96.  
21. MADOZ, L. V., I. PRUNNER, M. 
JAUREGUIBERRY, C. C. GELFERT, R. L. DE LA 
SOTA, M. J. GIULIODORI and M. DRILLICH 
(2017): Application of a bacteriological on-farm 
test to reduce antimicrobial usage in dairy cows 
with purulent vaginal discharge. J. Dairy Sci. 100, 
3875-3882.  
22. MAKKI, M., M. R. AHMADI, H. R. GHEISARI 
and S. NAZIFI (2017): Cure rate of postpartum 
endometritis after different treatments in high 
produce dairy cows. Comp. Clin. Pathol. 26, 
921-928. 
23. MALINOWSKI, E., H. LASSA, H. MARKIEWICZ, 
M. KAPTUR, M. NADOLNY, W. NIEWITECKI 
and J. ZIĘTARA (2011): Sensitivity to antibiotics of 
Arcanobacterium pyogenes and Escherichia coli from 
the uteri of cows with metritis/endometritis. Vet. J. 
187, 234-238. 
24. MARI, G., E. IACONO, F. TONI, P. G. PREDIERI and 
B. MERLO (2012): Evaluation of the effectiveness of 
intrauterine treatment with formosulphathiazole 
of clinical endometritis in postpartum dairy cows. 
Theriogenology 78, 189-200.  
25. MIDO, S., N. MURATA, M. S. RAWY, G. 
KITAHARA and T. OSAWA (2016): Effects of 
intrauterine infusion of povidone-iodine on 
endometrial cytology and bacteriology in dairy 
cows with clinical endometritis. J. Vet. Med. Sci. 78, 
551-556.  
26. PLÖNTZKE, J., L.V. MADOZ, R. L. DE LA SOTA, 
W. HEUWIESER and M. DRILLICH (2011): 
Prevalence of clinical endometritis and its impact 
on reproductive performance in grazing dairy cattle 
in Argentina. Reprod. Domest. Anim. 46, 520-526. 
27. RUNCIMAN, D., G. ANDERSON and J. MALMO 
(2009): Comparison of two methods of detecting 
purulent vaginal discharge in postpartum dairy 
cows and effect of intrauterine cephapirin on 
reproductive performance. Aust. Vet. J. 87, 369-378. 
28. SANTOS, T. M. A., L. S. CAIXETA, V. S. MACHADO, 
A. K. RAUF, R. O. GILBERT and R. C. BICALHO 
(2010): Antimicrobial resistance and presence of 
virulence factor genes in Arcanobacterium pyogenes 
isolated from the uterus of postpartum dairy cows. 
Vet. Microbiol. 145, 84-89.  
29. SHELDON, I. M. (2004): The postpartum 
uterus. Vet. Clin. North. Am. Food. Anim. 
Pract. 20, 569-591. 
30. SHELDON, I. M., G. S. LEWIS, S. J. LEBLANC and 
R. O. GILBERT (2006): Defining postpartum uterine 
disease in cattle. Theriogenology 65, 1516-1530. 
31. SHELDON, I. M., J. CRONIN, L. GOETZE, G. 
DONOFRIO and H. J. SCHUBERTH (2009a): 
Defining postpartum uterine disease and the 
mechanisms of infection and immunity in the 
female reproductive tract in cattle. Biol. Reprod. 8, 
1025-1032. 
32. SHELDON, I. M., S. PRICE, J. CRONIN, R. O. 
GILBERT and J. GADSBY (2009b): Mechanisms of 
infertility associated with clinical and subclinical 
endometritis in high producing dairy cattle. 
Reprod. Domest. Anim. 44, 1-9. 
33. SHELDON, I. M. and S. E. OWENS (2017): 
Postpartum uterine infection and endometritis 
in dairy cattle. Proceedings of the 33rd Annual 
Scientific Meeting of the European Embryo Transfer 
Association (AETE); Bath, United Kingdom, 
September 8th and 9th. 
34. SLAMA, H., D. VAILLANCOURT, and A. K. GOFF 
(1993): Leukotriene B4 in cows with normal calving 
and in cows with retained fetal membranes and/or 
uterine subinvolution. Can. J. Vet. Res. 57, 293-299.
35. SZENCI, O., Z. SZELÉNYI, L. LÉNÁRT, D. 
BUJÁK, L. KOVÁCS, L. F. KÉZÉR, B. HAN and 
A. HORVÁTH (2018): Importance of monitoring 
the peripartal period to increase reproductive 
performance in dairy cattle. Vet. stn. 49, 297-307. 
Cefacetrile and Rifaximin association might improve first service conception rate and reduce the number of services per conception in 
cows with clinical endometritis
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koncepciji u krava s kliničkim endometritisom
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Klinički endometritis (CE) jedna je od 
glavnih značajnih bolesti koja dovodi do 
lošeg reproduktivnog učinka mliječnih krava 
u laktaciji, a time smanjujući profitabilnost 
farme. Da bi se sačuvala optimalna 
reproduktivna učinkovitost, predložene su 
različite moguće strategije i terapijski pristupi 
za krave s CE-om, često s kontradiktornim 
rezultatima. Iz tog je razloga istraživanje 
novih načina liječenja CE-a ekonomski bitno. 
Cilj ove studije bio je ispitati učinkovitost tri 
različita terapijska protokola na postotak 
kliničkog izlječenja CE-a te poboljšanje 
reproduktivne učinkovitosti. Krave (n=42), 
na 21.-38. dan laktacije (DIM), s CE-om 
raspoređene su u tri terapijske skupine; PGF: 
krave (n=19) su sistematski liječene s dvije doze 
d-kloprostenola, sintetičkog analoga PGF2α, 
14-dnevni interval; CEFAX: krave (n=10) su 
primale intrauterinu infuziju kombinacije 
antibiotika cefacetrila i rifaksimina; NAX: 
krave (n=13) su primale sistemsku terapiju s 
ceftiofur kristaliničnom slobodnom kiselinom 
(CCFA). Trideset i šest (n=36) krava bez 
CE-a (zdrava skupina: HE) uključeno je kao 
kontrolna skupina. Sve krave su ponovno 
klinički pregledane nakon kraja protokola 
liječenja. Postotak kliničkog izlječenja iznosio 
je 73,7 %, 80 % i 69,2 % u PGF, CEFAX, 
odnosno NAX skupini (P>0,05). HE skupina 
imala je značajno kraći interval između teljenja 
do prvog osjemenjivanja u usporedbi s CEFAX 
i PGF skupinama (P<0,05), no razlika nije bila 
značajna s NAX skupinom. Srednji interval od 
teljenja do osjemenjivanja za oplodnju (CFI) 
bio je nešto veći u tri terapijske skupine u 
usporedbi s HE skupinom, ali razlika nije bila 
značajna (P>0,05). CEFAX protokol rezultirao 
je kraćim, ali ne statistički značajnim CFI u 
usporedbi s PGF i NAX protokolima. Indeks 
osjemenjivanja po koncepciji bio je nešto niži 
(1,7) u CEFAX skupini u usporedbi s HE 
(1,75), PGF (1,84) i NAX (2,23) skupinama, 
međutim razlika nije bila značajna između 
sve četiri skupine. Postotak prvog uspješnog 
osjemenjivanja i postotak koncepcije na 105. 
DIM nisu se statistički razlikovale među 
terapijskim skupinama. Premda razlika nije 
bila značajna, CEFAX protokol imao je nešto 
bolji postotak izlječenja za CE, smanjujući 
broj osjemenjivanja po koncepciji i potičući 
ponovnu aktivnost jajnika nakon teljenja. 
Validacija ovog otkrića na većem krdu 
poboljšat će točnost ovih rezultata. 
Ključne riječi: klinički endometritis, liječenje, 
postotak izlječenja, reproduktivna učinkovitost
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